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Abstract Purpose The amount of atherosclerotic
plaque and its components (calciﬁcations, ﬁbrous
tissue, and lipid core) could be better predictors of
acute events than the now currently used degree of
stenosis. Therefore, we evaluated a dedicated soft-
ware tool for volume measurements of atherosclerotic
carotid plaque and its components in multidetector
computed tomography angiography (MDCTA) images.
Materials and Methods Data acquisition was approved
by the Institutional Review Board and all patients
gave written informed consent. MDCTA images of
56 carotid arteries were analyzed by three observers.
Plaque volumes were assessed by manual drawing of
the outer vessel contour. The luminal boundary was
determined based on a Hounsﬁeld-Unit (HU) thresh-
old. The contribution of different components was
measured by the number of voxels within deﬁned
ranges of HU-values (calciﬁcation[130 HU, ﬁbrous
tissue 60–130 HU, lipid core\60 HU). Interobserver
variability (IOV) was assessed. Results Plaque volume
was 1,259 ± 621 mm
3. The calciﬁed, ﬁbrous and
lipid volumes were 238 ± 252 mm
3,6 4 7± 277 mm
3
and 376 ± 283 mm
3, respectively. IOV was moder-
ate with interclass correlation coefﬁcients (ICC)
ranging from 0.76 to 0.99 and coefﬁcients of varia-
tion (COV) ranging from 3% to 47%. Conclusion
Atherosclerotic carotid plaque volume and plaque
component volumes can be assessed with MDCTA
with a reasonable observer variability.
Introduction
It is well known that the severity of stenosis is an
unreliable estimation of the amount of atherosclerotic
plaque. In case of carotid atherosclerotic disease, this
is both related to the carotid bulb, in which athero-
sclerotic plaque accumulates before it compromises
the lumen, and to positive remodeling, the phenom-
enon that an artery may or may not enlarge in
response to plaque accumulation [1]. Furthermore, it
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plays an important role in acute events, like transient
ischemic accidents (TIA) and minor stroke [2].
Rupture-prone plaques have speciﬁc morphological
features: the most frequently seen vulnerable plaque
type has a large lipid-rich core with a thin ﬁbrous cap
[2] and has proved to be an independent predictor of
ischemic cerebrovascular events [3].
It is therefore hypothesized that the amount of
atherosclerotic plaque and its components (calciﬁca-
tions, ﬁbrous tissue, and lipid core) could be better
predictors of acute events than the now clinically
used degree of stenosis, and may be useful in the
selection of patients who could beneﬁt from thera-
peutic intervention.
Computed tomography angiography (CTA) has
been established as an accurate modality to assess the
presence of carotid atherosclerotic plaque and grade
the severity of stenosis [4]. A recent in vitro and
in vivo study showed that quantiﬁcation of the area
(two dimensional) of atherosclerotic carotid plaque
and its components is possible in axial thin section
multidetector computed tomography angiography
(MDCTA) images, in good correlation (R
2[0.73)
with histology [5, 6]. Further developments in the
quantiﬁcation software now enable to quantify the
volume of atherosclerotic plaque and the volume of
different plaque components (three dimensional).
The aim of this study was to evaluate this software
tool for atherosclerotic plaque and plaque component
volume measurements in MDCTA images of the





NASCET [7] criteria) and twelve patients for each of
the three other stenosis grades (30–49%; 50–69% and
70–99%) at the symptomatic side were retrieved at
random from a database (n = 421) of MDCTA
examinationsofpatientswithtransientischemicattack
or minor stroke. In all 56 patients MDCTA had been
performed as part of a research protocol that was
approved by the Institutional Review Board and for
which all patients had given written informed consent.
Scanning and image reconstruction
Scanning was performed on a 16-slice MDCT
scanner (Siemens, Sensation 16, Erlangen, Germany)
with a standardized protocol (120 kVp, 180 mAs,
collimation 16 9 0.75 mm, table feed 12 mm/rota-
tion, pitch 1) [8]. All patients received 80 ml contrast
material (320 mg/ml), followed by 40 ml saline, both
with an injection rate of 4 ml/s [9]. The radiation
dose was 2.6 mSv.
Image reconstructions were made with ﬁeld of
view 120 mm, matrix size 512 9 512 (yielding
interpolated pixels of 0.2 9 0.2 mm, real in-plane
resolution is 0.6 9 0.6 mm), slice thickness 1.0 mm,
increment 0.6 mm and with an intermediate recon-
struction algorithm (B46: heart-view sharp) [6].
Quantiﬁcation and characterization
Three observers independently assessed the presence
of an atherosclerotic lesion, the length of the
atherosclerotic lesion, the location of the bifurcation,
lumen attenuation, and plaque volume and plaque
component volumes. One of the observers assessed
after 4 months for a second time the volumes in a
subset of patients (half the population per stenosis
degree, randomly chosen).
The criterion used for the presence of an athero-
sclerotic lesion was: the presence of a calciﬁcation
and/or thickening of the vessel wall. The length of the
atherosclerotic lesion was deﬁned as the distance
between the ﬁrst (most proximal) image and the last
(most distal) image on which the atherosclerotic
lesion was present. The location of the bifurcation
was deﬁned as the ﬁrst image with two separate
lumina. Lumen attenuation was measured in the most
proximal and distal image with atherosclerosis, and
the mean lumen attenuation was calculated.
Plaque and plaque component areas were mea-
sured with a polymeasure plug-in developed by one
of the co-authors (E.M.) for the freely available
software package ImageJ (Rasband, National Institute
of Mental Health, Bethesda, USA). This plug-in
made it possible to draw manually regions of interest
(ROI) in consecutive axial MDCT images and to
automatically calculate the total number of pixels and
the number of pixels of different Hounsﬁeld value
(HV) ranges within these ROI (Fig. 1). The ROI was
placed over the outer vessel wall contour and
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123therefore equals plaque area plus lumen area. The
different HV ranges are considered to represent the
different plaque components; calciﬁcation[130 HU,
ﬁbrous tissue 60–130 HU and lipid core\60 HU.
The cut-off value between calciﬁcations and
ﬁbrous tissue was set at 130 HU; the value currently
used for calcium scoring. The cut-off value between
ﬁbrous tissue and lipid core was set at 60 HU as
assessed in previous studies [5, 6]. The cut-off value
between atherosclerotic plaque and lumen was
adjusted for each patient and based on the full-
width-half-maximum principle (mean lumen attenu-
ation plus mean ﬁbrous tissue attenuation (&88 HU)
divided by two). To compensate for partial volume
effects, related to a high lumen attenuation at the
plaque-lumen border, the pixels around the lumen
with a HV between 130 HU and the adjusted cut-off
value were considered to be ﬁbrous tissue. To assess
the border between lumen and atherosclerotic plaque
it was necessary to draw a second ROI close to the
lumen in each image. Normally, the lumen area was
then automatically differentiated from atherosclerotic
plaque based on the adjusted cut-off value. But in
those plaques in which calciﬁcations bordered the
lumen and the two dense structures merged with each
other, lumen area and calciﬁcations had to be
separated by manual drawing.
The volumes were calculated as the product of the
number of pixels, the pixel size and the increment.
Analysis
Firstly, the difference between observers in the
assessment of the presence of an atherosclerotic
lesion was assessed. Hereafter, consensus on the
presence of an atherosclerotic lesion was achieved by
a consensus reading between all three observers.
Those image series that were appointed as having
atherosclerosis were used for further analysis.
Secondly, differences between observers in the
assessment of the length of the atherosclerotic lesion,
the location of the bifurcation, lumen attenuation
and plaque and plaque component volumes, were
calculated.
Fig. 1 Semi-automatic assessment of plaque component
volumes in a stack of MDCTA images with the ImageJ plug-
in ‘PolyMeasure’. (a1) This plug-in allows an observer to draw
a region of interest (ROI) on consecutive axial MDCTA images.
This ROI represents lumen area and atherosclerotic plaque area.
(a2) To differentiate lumen area from the atherosclerotic plaque
area and from calciﬁed tissue, a second ROI is drawn. This
second ROI should include the attenuated lumen area, but
should not include any calciﬁcations. (a3) After the input of the
cut-off values that differentiate the speciﬁc plaque components
and the lumen, the plaque components and the lumen can
be labeled with a color. After the input of the voxel sizes,
(a4) atherosclerotic plaque component volumes and lumen
volume are automatically calculated, and (a5) color overlay
images are produced on which the plaque components and the
lumen have a speciﬁc color
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123After assessment of the differences, a second
consensus reading was held in order to achieve
consensus about the length of the atherosclerotic
lesion, the location of the bifurcation and lumen
attenuation because these features inﬂuence the
volume measurements. All observers had to adapt
their assessments on grounds of this second consen-
sus reading and hereafter plaque and plaque compo-
nent volumes were calculated again and differences
were evaluated. This recalculation provides observer
variability measurements due to differences in the
assessment of the outer vessel wall contour only.
In order to assess not only the variability in
volume measurements, the overlap (similarity index)
between the ROIs (outer contour) of the observers
was assessed and expressed as a percentage (2 9 pix-
els with overlap/(pixels ROI observer A + pixels
ROI observer B)9 100%).
Finally, the intra-observer differences in plaque
and plaque component volume measurements were
assessed.
Statistics
Continuous data were compared with a paired
Student’s t-test for which a P-value\0.05 was con-
sidered to indicate statistical signiﬁcance.
Inter-observer differences in the assessment of the
length of the atherosclerotic lesion, the location of the
bifurcation and lumen attenuation were expressed as
the mean ± the standard deviation (SD), and as a
coefﬁcient of variation deﬁned by the SD of the paired
difference divided by the mean of the absolute values.
Inter- and intra-observer differences in plaque and
plaque component volume measurements were pre-
sented with a mean ± SD, an interclass correlation
coefﬁcient (ICC) with 95% conﬁdence interval and a
coefﬁcient of variation. The differences were also
plotted against the mean value of the measurements
(Bland-Altman plot).
Results
In the 36 patients with a stenosis degree of 30% or
higher, all observers agreed on the presence of an
atherosclerotic lesion. In the 20 patients with 0–29%
stenosis, the presence of an atherosclerotic lesion was
determined in 9 patients by three observers, in 1
patient by two observers, and in 1 patient by one
observer. The consensus reading appointed 10
patients as having atherosclerosis, thus 46 patients
were selected for further analysis.
The mean time used by an observer for the
analysis of one artery was about 1 h, almost entirely
taken by the drawing of the outer vessel wall.
The assessment of the length of an atherosclerotic
lesion was signiﬁcantly different between observers,
while the assessment of the location of the bifurcation
and lumen attenuation was not signiﬁcantly different
(P[0.27 and P[0.49, respectively).
The ICC was good for all volume measurements
(range 0.53–0.96). The plaque and plaque component
volumes measured by the three observers were
signiﬁcantly different and the coefﬁcients of variation
(COV) were moderate (range 13–58%) (Table 1).
After the second consensus reading in which
consensus was achieved about the length of the
atherosclerotic lesion, the location of the bifurcation
and lumen attenuation, the ICC improved and was
excellent for all volume measurements (ICC[0.80),
except for the lipid core volume measurements
(ICC = 0.76 (0.54–0.87)), for which it was good
(Table 2). The coefﬁcients of variation between
observers improved for all measurements: plaque
volume (17–24%), calciﬁed volume (13–33%), ﬁbrous
tissue volume (18–24%), lipid core volume (37–47%)
and lumen volume (3–10%) (Table 2). The COV
between observers for the assessment of calciﬁed
volume percentage (15–26%), ﬁbrous volume per-
centage (10–15%) and lipid core volume percentage
(21–30%) were also improved (Table 2).
From the Bland-Altman plots it can be observed
that especially the differences between observers in
plaque volume, ﬁbrous tissue volume and lipid core
volume measurements increase with a larger volume
(see supplemental ﬁles, Fig. I).
The similarity indices (±SD) between the ROIs
assessed by observer 1 and 2, observer 1 and 3, and
observer 2 and 3 were 91.3 ± 3.0%, 90.9 ± 2.9%
and 90.0 ± 4.5%, respectively.
Intra-observer analysis was good with excellent
ICC (all [0.94) and moderate to good COV for the
assessment of plaque volume (11%), calciﬁed volume
(8%), ﬁbrous tissue volume (8%), lipid core volume
(25%) and lumen volume (5%) (Table 3). The intra-
observer COV for the assessment of calciﬁed volume
percentage (10%), ﬁbrous volume percentage (6%)
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123and lipid core volume percentage (14%) were also
good (Table 3).
The similarity index (±SD) between the two series
of independently assessed ROIs by observer 1 was
93.7 ± 1.8%.
Discussion
Non-invasive in vivo assessment of atherosclerotic
plaque volume and the relative contribution of the
different plaque components will have important
clinical implications: it provides new and probably
better parameters, together with the severity of
stenosis, for cardiovascular risk assessment, and
furthermore the natural history of atherosclerotic
disease and the effect of pharmacological interven-
tion can be studied [10]. MDCTA has extensively
been used to assess the severity of luminal narrowing,
and nowadays attention is increasingly paid to the
potential role of MDCTA in qualitative and quanti-
tative evaluation of the atherosclerotic plaque itself.
Validation studies in which image-based plaque
features are compared with histology, as well as
assessment of observer variability, are necessary to
establish the ﬁnal role of MDCTA in qualitative and
quantitative atherosclerotic plaque evaluation.
Until now a few coronary in vivo studies have
compared the plaque volume assessed with MDCTA
and intravascular ultrasound (IVUS). One study
Table 2 Mean values, inter-observer differences, interclass
correlation coefﬁcients, coefﬁcients of variation of volume
measurements from 46 CTA datasets in which atherosclerosis
was considered to be present and consensus was reached with
regard to the lesion length, location of bifurcation and lumen
attenuation
Mean ± SD Diff Obs 1–2 Diff Obs 1–3 Diff Obs 2–3 ICC (95 % CI) CoV (range) (%)
Plaque volume (mm
3) 1,223 ± 606 26 ± 194 218 ± 255* 192 ± 300* 0.88 (0.75–0.94) 17–24
Calciﬁed volume (mm
3) 235 ± 250 28 ± 60* 4 ± 28 31 ± 78* 0.97 (0.95–0.98) 13–33
Fibrous volume (mm
3) 619 ± 264 21 ± 72* 67 ± 88* 87 ± 106* 0.90 (0.78–0.95) 18–24
Lipid volume (mm
3) 369 ± 278 20 ± 120 150 ± 168* 130 ± 186* 0.76 (0.54–0.87) 37–47
Luminal volume (mm
3) 830 ± 421 13 ± 76 6 ± 21 18 ± 86 0.99 (0.98–0.99) 3–10
Calciﬁed volume (%) 18 ± 15 2 ± 4* 2 ± 3* 4 ± 5* 0.95 (0.89–0.98) 15–26
Fibrous volume (%) 54 ± 12 2 ± 63 ± 5* 1 ± 8 0.84 (0.76–0.91) 10–15
Lipid volume (%) 27 ± 13 0 ± 75 ± 6* 5 ± 8* 0.81 (0.66–0.89) 21–30
* = t-test P value\0.05; Diff = Difference; Obs = Observer; CoV = Coefﬁcient of variation; ICC = Interclass correlation;
CI = Conﬁdence interval
Table 1 Mean values, inter-observer differences, interclass correlation coefﬁcients, coefﬁcients of variation of atherosclerotic
plaque features and volume measurements from 46 CTA datasets in which atherosclerosis was considered to be present
Mean ± SD Diff Obs 1–2 Diff Obs 1–3 Diff Obs 2–3 ICC 95% CI CoV (range) (%)
Lesion length (mm) 27.3 ± 10.6 6.1 ± 4.4* 1.7 ± 5.2* 4.3 ± 6.2* – –
Image with bifurcation (mm
2) – 0.5 ± 3.6 0.3 ± 1.7 0.2 ± 3.2 – –
Lumen attenuation (HU) 217.4 ± 36.9 0.4 ± 5.9 0.7 ± 3.9 0.2 ± 5.8 – –
Plaque volume (mm
3) 1,259 ± 621 167 ± 278* 247 ± 381* 80 ± 446 0.79 (0.65–0.87) 23–34
Calciﬁed volume (mm
3) 238 ± 252 37 ± 68* 3 ± 38 40 ± 82* 0.96 (0.93–0.98) 13–34
Fibrous volume (mm
3) 647 ± 277 77 ± 144* 92 ± 191* 15 ± 210 0.76 (0.63–0.85) 23–31
Lipid volume (mm
3) 376 ± 283 48 ± 141* 153 ± 204* 105 ± 236* 0.70 (0.51–0.82) 42–58
Luminal volume (mm
3) 879 ± 459 182 ± 206* 51 ± 226 132 ± 240* 0.84 (0.71–0.91) 23–27
Calciﬁed volume (%) 19 ± 15 1 ± 94 ± 9* 2 ± 6* 0.85 (0.77–0.91) 33–48
Fibrous volume (%) 54 ± 12 2 ± 14 0 ± 13 2 ± 7* 0.53 (0.36–0.69) 13–27
Lipid volume (%) 27 ± 13 1 ± 11 3 ± 11* 5 ± 8* 0.68 (0.53–0.80) 30–44
* = t-test P value\0.05; Diff = Difference; Obs = Observer; CoV = Coefﬁcient of variation; ICC = Interclass correlation;
CI = Conﬁdence interval
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123found a strong correlation (r = 0.8) and an underes-
timation of the coronary plaque volume assessed with
MDCT compared to IVUS [11]. Another study found
a moderate correlation (r = 0.55) and an overesti-
mation of coronary plaque area assessed with
MDCTA compared to IVUS [12]. The discrepancies
between these studies might be explained by the
results of a third study that found a strong correlation
coefﬁcient (r
2 = 0.69) with an underestimation of
mixed and noncalciﬁed plaque volumes, and a trend
to overestimate calciﬁed plaque volumes with
MDCTA. In addition, they reported a moderate
reproducibility in the assessment of plaque volume,
with a coefﬁcient of variation of 37% [13].
An in vivo study [5] on carotid atherosclerotic
plaques revealed a strong correlation between MDCTA
and histology for the assessment of plaque area
(r
2 = 0.73); in addition, the inter- and intra-observer
variability of plaque area measurements with MDCTA
wasreasonablewithCOVof19%and8%,respectively.
Toourknowledge,thepresentstudyistheﬁrststudy
that shows that in vivo quantiﬁcation of the volume of
atherosclerotic carotid plaque and its components is
possible with MDCTA (Fig. 2). Inter-observer vari-
ability was moderate with ICC ranging from 0.53 to
0.96 and COV ranging from 13% to 58%. To evaluate
the inter-observer variability caused by the manual
drawing of the contours we re-evaluated the data after
consensus was reached with regard to the length of
atherosclerotic disease, the location of the bifurcation
and lumen attenuation, because all these features also
inﬂuenced the volume measurements. This led to a
decreased variability with ICC ranging from 0.76 to
0.99andCOVrangingfrom3%to47%.Intra-observer
variabilitywaslesswithICCrangingfrom0.94to1.00
and COV ranging from 5% to 25%.
The ﬁrst problem which causes a variability in
volume measurements is the differentiation between
a normal vessel wall and a slightly thickened
(diseased) vessel wall. In a number of cases, observ-
ers disagree with regard to the presence of
atherosclerotic disease in carotid arteries with a
stenosis of 0–29%. In such cases, the assessed plaque
volume in such patients will be very low; the
measured plaque volume in the two arteries in which
the observers disagree on the presence of atheroscle-
rotic disease was 609 and 245 mm
3, while the mean
plaque volume of all patients was 1,259 ± 621 mm
3.
Furthermore, the difﬁculty in differentiation
between a normal vessel wall and a slightly thickened
(diseased) vessel wall, inﬂuences the assessment of
the most proximal and distal image with atheroscle-
rosis and thus the length of the atherosclerotic lesion.
Because the plaque volume measurements include
the original vessel wall, inclusion of additional
images with normal vessel wall increases the amount
of measured volumes considerably.
The second problem is the manual outlining of the
outerborderofthevesselwall.Somepartsofthevessel
wall can easily be differentiated from the surrounding
tissue due to the low density of peri-arterial fat or the
presence of calciﬁcations at the outer border of the
plaque. However, other parts have the same density as
the peri- and paravertebral and sternocleidomastoid
muscle, which are frequently positioned along the
artery. The erroneous manual inclusion of peri-arterial
fat in the ROI leads to the classiﬁcation of this fat as
lipid in the plaque. This inclusion will vary between
Table 3 Mean values, intra-observer differences, interclass
correlation coefﬁcients, coefﬁcients of variation of volume
measurements from 46 CTA datasets in which atherosclerosis
was considered to be present and consensus was reached with
regard to the lesion length, location of bifurcation and lumen
attenuation
Mean ± SD Difference ICC (95% CI) CoV (%)
Plaque volume (mm
3) 1,098 ± 459 1 ± 120 0.97 (0.93–0.99) 11
Calciﬁed volume (mm
3) 218 ± 186 7 ± 18 0.99 (0.99–1.00) 8
Fibrous volume (mm
3) 591 ± 229 10 ± 49 0.98 (0.95–0.99) 8
Lipid volume (mm
3) 289 ± 205 2 ± 72 0.94 (0.87–0.97) 25
Luminal volume (mm
3) 824 ± 413 14 ± 40 1.00 (0.99–1.00) 5
Calciﬁed volume (%) 20 ± 16 1 ± 2 0.99 (0.98–1.00) 10
Fibrous volume (%) 56 ± 12 1 ± 3 0.96 (0.91–0.98) 6
Lipid volume (%) 24 ± 11 0 ± 3 0.96 (0.91–0.96) 14
* = t-test P value\0.05; ICC = Interclass correlation; CI = Conﬁdence interval; CoV = Coefﬁcient of variation
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123theobserverswhichexplainsthemoderateICCandthe
high observer variability in the assessment of lipid
volume. The Bland-Altman plots conﬁrm this by
showing that the differences in lipid volume between
observers1and3,and2and3dependonthesizeofthe
assessed volume, suggesting that observer 3 system-
atically draws a larger outer contour than the other
observers and thus includes more peri-arterial low
density tissues. An additional problem in the assess-
ment of the outer border of the vessel wall is, that the
size of calciﬁcations is inﬂuenced by differences in
window-level setting. Because these calciﬁcations are
oftenlocatedattheborderofanatheroscleroticplaque,
differentwindow-levelsettingsbetweenobserverswill
inﬂuence the assessment of the outer vessel wall
betweenobservers,andtherebyintroducevariabilityin
theassessmentofplaquevolumeandcalciﬁedvolume.
The third problem is the differentiation of contrast-
enhanced lumen from atherosclerotic plaque. In some
plaque without calciﬁcations at the inner border of the
plaque the differentiation is automated and based on a
threshold and the only variability is caused by a
difference in the measurement of luminal attenuation,
which was fortunately low. In case a calciﬁcation
Fig. 2 One mm
multiplanar reformat (a)
and 2 mm maximum
intensity projection (b)i n
the sagittal plane depicts the
carotid bifurcation with an
atherosclerotic plaque. The
startpoint (Im 1) and
endpoint (Im 50) of
atherosclerotic plaque
volume assessment in this
patient, and the position
(C, D, E) of the three thin
sliced (0.75 mm ) axial
MDCT images (c, d and e)
of the internal carotid artery





1) are indicated. A
graphical representation of
the absolute (f) and relative
(g) volume measurements
of lumen, calciﬁcations,
ﬁbrous tissue, and lipid per
MDCT image. The x-axis
represents the consecutive
MDCT images, the y-axis
represents the volume. (h)
A table with the total
lumen, total calciﬁed, total
ﬁbrous tissue and total lipid
volume
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123borders the lumen, a threshold based approach would
merge the lumen with the calciﬁcation. In such cases
manual drawing of the border between lumen and
calciﬁcation was necessary which introduced a vari-
ability in plaque volume and calcium volume
measurements.
We expect that improvements in the measurement
software will improve the observer variability.
Although in our method we assessed volumes, the
analysis was performed in axial two-dimensional
images. Evaluating the artery both in axial slices and
using longitudinal reformats will provide more
information on the borders of the vessel wall. This
would enable a better continuation of transversal
contours in adjacent slices. Also, highlighting speciﬁc
parts of the vessel outer contour in axial images based
on outer vessel contour assessment in longitudinal
planes might be helpful. Finally, the differentiation
between normal vessel wall and slightly thickened
vessel wall can be based on wall thickness measure-
ments, and the length of the atherosclerotic disease
can be assessed more reproducibly.
Besides MDCTA, MRI has been used for non-
invasive atherosclerotic carotid plaque characteriza-
tion and quantiﬁcation. Studies have shown that there
is good agreement between in vivo MRI and histology
for qualitative [14–16] and quantitative [17] assess-
ment of plaque components, while observer repro-
ducibility has shown tobe good to excellent for plaque
area [14–16, 18] and plaque component areas [19].
ICC for plaque area were 0.90–0.96 and for lipid core
0.88–0.89. The reproducibility of MRI-based plaque
volume measurements has not been extensively stud-
ied.Onestudyreportedacoefﬁcientofvariationforan
averaged (over 5 slices) plaque area of 3.5% [20],
while another study reported a coefﬁcient of variation
of 9.8% for plaque volume [20].
Untilnowcarotidintima-mediathickness(CIMT)is
a validated endpoint in progression/regression studies.
CIMT has shown to be an independent risk factor for
futuremyocardialinfarctionandstrokerisk[21,22].In
addition, CIMT has been related to the presence of
future carotid plaque [23]. Lifestyle changes [24] and
statin therapy [25] has a beneﬁcial effect on CIMT.
Ultrasound assessment of CIMT is accurate when
compared with histology [26, 27], and has a very good
reproducibility (coefﬁcient of variation 2.4–10.6%)
[28]. Interscan coefﬁcient of variation is 5.6% [28],
making it a potential valuable tool to evaluate the
effectiveness of prevention therapy. Unfortunately,
CIMT does not provide us with area and volumetric
measurements of the plaque and ignores the presence
of different plaque components. This makes CIMT
unsuitable for the precise evaluation of pharmacolog-
ical effects on the advanced atherosclerotic plaque.
The present study investigated the reproducibility
of MDCTA-based atherosclerotic plaque volume
measurements. It is a limitation that validation with
histology has not been performed. Because we inves-
tigated a range of carotid artery stenoses, athero-
sclerotic specimens were not available in most of the
patients. In the patients with a stenosis of more than
70% stent placement or surgery was performed.
Previous studies [5, 6], however, have demonstrated
a good correlation between area measurements with
MDCTA and histology. A second limitation is the
inclusion of the vessel wall (tunica media) in the
plaque volume measurements. With MDCTA it is not
possible to differentiate between the atherosclerotic
plaque and the tunica media. This will lead to a
systematic overestimation of plaque volume measure-
ments. It is not expected that this overestimation will
be a problem for serial evaluation or risk prediction.
Conclusion
In vivoassessmentofatheroscleroticplaqueandplaque
component volumes in carotid arteries with MDCTA is
feasible with a moderate reproducibility. A prospective
longitudinal study which examines the relationship
between cardiovascular risk factors, plaque and plaque
component volumes and outcome may determine the
value of MDCTA-based stroke risk predictors.
Acknowledgements ThisresearchwassupportedbyEconomic
Affairs innovation grant IS044070 Automatic Diagnostic
Vascular Analysis of CTA Examinations (ADVANCE)
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which
permits any noncommercial use, distribution, and reproduction
in any medium, provided the original author(s) and source are
credited.
References
1. Glagov S et al (1987) Compensatory enlargement of
human atherosclerotic coronary arteries. N Engl J Med
316:1371–1375
758 Int J Cardiovasc Imaging (2008) 24:751–759
1232. Naghavi M et al (2003) From vulnerable plaque to vul-
nerable patient: a call for new deﬁnitions and risk
assessment strategies: Part I. Circulation 108:1664–1672
3. Polak JF et al (1998) Hypoechoic plaque at US of the
carotid artery: an independent risk factor for incident
stroke in adults aged 65 years or older. Cardiovascular
health study. Radiology 208:649–654
4. Koelemay MJ et al (2004) Systematic review of computed
tomographic angiography for assessment of carotid artery
disease. Stroke 35:2306–2312
5. de Weert TT et al (2006) In vivo characterization and
quantiﬁcation of atherosclerotic carotid plaque components
with multidetector computed tomography and histopa-
thological correlation. Arterioscler Thromb Vasc Biol
26:2366–2372
6. de Weert TT et al (2005) In vitro characterization of ath-
erosclerotic carotid plaque with multidetector computed
tomography and histopathological correlation. Eur Radiol
15:1906–1914
7. Beneﬁcial effect of carotid endarterectomy in symptomatic
patients with high-grade carotid stenosis (1991) North
American symptomatic carotid endarterectomy trial col-
laborators. N Engl J Med 325:445–453
8. deMonyeCet al(2006)OptimizationofCTangiographyof
the carotid artery with a 16-MDCT scanner: craniocaudal
scan direction reduces contrast material-related perivenous
artifacts. AJR Am J Roentgenol 186:1737–1745
9. de Monye C et al (2005) Sixteen-detector row CT angi-
ography of carotid arteries: comparison of different
volumes of contrast material with and without a bolus
chaser. Radiology 237:555–562
10. Pulido MA et al (2004) Imaging of atherosclerotic plaque.
Int J Cardiovasc Imaging 20:553–559
11. Achenbach S et al (2004) Detection of calciﬁed and non-
calciﬁed coronary atherosclerotic plaque by contrast-
enhanced, submillimeter multidetector spiral computed
tomography: a segment-based comparison with intravas-
cular ultrasound. Circulation 109:14–17
12. Moselewski F et al (2004) Comparison of measurement of
cross-sectional coronary atherosclerotic plaque and vessel
areas by 16-slice multidetector computed tomography ver-
sus intravascular ultrasound. Am J Cardiol 94:1294–1297
13. Leber AW et al (2006) Accuracy of 64-slice computed
tomography to classify and quantify plaque volumes in the
proximal coronary system: a comparative study using
intravascular ultrasound. J Am Coll Cardiol 47:672–677
14. Cai J et al (2005) In vivo quantitative measurement of
intact ﬁbrous cap and lipid-rich necrotic core size in ath-
erosclerotic carotid plaque: comparison of high-resolution,
contrast-enhanced magnetic resonance imaging and his-
tology. Circulation 112:3437–3444
15. Trivedi RA et al (2004) Multi-sequence in vivo MRI can
quantify ﬁbrous cap and lipid core components in human
carotid atherosclerotic plaques. Eur J Vasc Endovasc Surg
28:207–213
16. Saam T et al (2005) Quantitative evaluation of carotid
plaque composition by in vivo MRI. Arterioscler Thromb
Vasc Biol 25:234–239
17. Yuan C et al (1998) Measurement of atherosclerotic car-
otid plaque size in vivo using high resolution magnetic
resonance imaging. Circulation 98:2666–2671
18. Takaya N et al (2006) Intra- and interreader reproducibility
of magnetic resonance imaging for quantifying the lipid-
rich necrotic core is improved with gadolinium contrast
enhancement. J Magn Reson Imaging 24:203–210
19. Corti R et al (2001) Effects of lipid-lowering by simva-
statin on human atherosclerotic lesions: a longitudinal
study by high-resolution, noninvasive magnetic resonance
imaging. Circulation 104:249–252
20. Adams GJ et al (2004) Tracking regression and progres-
sion of atherosclerosis in human carotid arteries using
high-resolution magnetic resonance imaging. Magn Reson
Imaging 22:1249–1258
21. O’Leary DH et al (1999) Carotid-artery intima and media
thickness as a risk factor for myocardial infarction and
stroke in older adults. Cardiovascular health study collab-
orative research group. N Engl J Med 340:14–22
22. Touboul PJ et al (2005) Carotid intima-media thickness,
plaques, and Framingham risk score as independent
determinants of stroke risk. Stroke 36:1741–1745
23. Zureik M et al (1999) Cross-sectional and 4-year longitu-
dinal associations between brachial pulse pressure and
common carotid intima-media thickness in a general pop-
ulation. The EVA study. Stroke 30:550–555
24. Markus RA et al (1997) Inﬂuence of lifestyle modiﬁcation
on atherosclerotic progression determined by ultrasono-
graphic change in the common carotid intima-media
thickness. Am J Clin Nutr 65:1000–1004
25. Probstﬁeld JL et al (1995) Results of the primary outcome
measure and clinical events from the asymptomatic carotid
artery progression study. Am J Cardiol 76:47C–53C
26. Wong M et al (1993) Ultrasonic-pathological comparison
of the human arterial wall. Veriﬁcation of intima-media
thickness. Arterioscler Thromb 13:482–486
27. Pignoli P et al (1986) Intimal plus medial thickness of the
arterial wall: a direct measurement with ultrasound imag-
ing. Circulation 74:1399–1406
28. Sramek A et al (2000) Ultrasound assessment of athero-
sclerotic vessel wall changes: reproducibility of intima-
media thickness measurements in carotid and femoral
arteries. Invest Radiol 35:699–706
Int J Cardiovasc Imaging (2008) 24:751–759 759
123